David Vicente

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

Medicine, Oncology, Radiation Oncology +15

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Comprehensive molecular characterization of mitochondrial genomes in human cancers

Yuan Yuan, Young Seok Ju, Young-Wook Kim et al. · Nature Genetics · 2020 · 515 citations · Full text

Life Sciences, Genetics, Oncology +14

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC

Jhanelle E. Gray, Augusto Villegas, Davey B. Daniel et al. · Journal of Thoracic Oncology · 2019 · 434 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Genomic footprints of activated telomere maintenance mechanisms in cancer

Chen Hong, Sandra D. Koser, Philip Ginsbach et al. · Nature Communications · 2020 · 139 citations · Full text

Medicine, Genetics, Oncology +17